MajesTEC-4: Phase 3 trial of Teclistamab plus Lenalidomide versus Lenalidomide in patients with newly diagnosed multiple myeloma
63rd Annual Scientific Meeting of the British-Society-for-Haematology, Birmingham, England, 23 - 25 April 2023, vol.201, pp.57, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 201
- City: Birmingham
- Country: England
- Page Numbers: pp.57
- Ankara University Affiliated: Yes